Cell Source, Inc.: 10-K filed 2019-04-01

Name: Cell Source, Inc.: 10-K filed 2019-04-01
Creator: Cell Source, Inc.

What Cell Source, Inc. reported in its annual report filed 2019-04-01 (fiscal FY 2018): 19 published measures, 40 facts as tagged in accession 0001165527-19-000034.

This filing

Form: 10-K (annual report)
Filed: 2019-04-01
Fiscal period: fiscal FY 2018
Accession: 0001165527-19-000034 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-12-31	65,792	USD
At 2017-12-31	531,677	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-12-31	4,985,963	USD
At 2017-12-31	5,089,051	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2018-12-31	-4,920,171	USD
At 2017-12-31	-4,557,374	USD
At 2016-12-31	-6,242,949	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2018-12-31	18,934	USD
At 2017-12-31	371,048	USD
At 2016-12-31	3,735	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	-2,117,446	USD	365
2017-01-01 to 2017-12-31	-3,082,510	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	-2,002,114	USD	365
2017-01-01 to 2017-12-31	-2,287,814	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	1,650,000	USD	365
2017-01-01 to 2017-12-31	2,655,127	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-12-31	-16,670,333	USD
At 2017-12-31	-14,552,887	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	-2,006,143	USD	365
2017-01-01 to 2017-12-31	-2,292,803	USD	365

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	219,122	USD	365
2017-01-01 to 2017-12-31	174,970	USD	365

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2018-12-31	277,786	USD
At 2017-12-31	201,824	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	2,006,143	USD	365
2017-01-01 to 2017-12-31	2,292,803	USD	365

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	1,281,055	USD	365
2017-01-01 to 2017-12-31	815,947	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	274,937	USD	365
2017-01-01 to 2017-12-31	637,318	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-12-31	26,077,611	shares
At 2017-12-31	25,349,236	shares

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2018-12-31	2,582	USD
At 2017-12-31	2,582	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2018-12-31	532,790	USD
At 2017-12-31	749,244	USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	0	USD	365
2017-01-01 to 2017-12-31	407	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	-111,303	USD	365
2017-01-01 to 2017-12-31	-789,707	USD	365

Inspect the source

Entity: Cell Source, Inc. / CIK 0001569340
Captured: 2026-09-20T09:20:59.488Z
SEC response SHA-256: a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))